Fentanyl Buccal Tablet
Authors:
- Stephanie K A BlickSBStephanie K A Blick
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 66 (18) , 2387-2393
Abstract
▴ The fentanyl buccal tablet (FBT) is a new formulation of fentanyl that uses an effervescent drug delivery system to enhance penetration across the buccal mucosa for the treatment of breakthrough pain in opioid-tolerant patients with cancer. ▴ Fentanyl is rapidly absorbed from FBT across the buccal mucosa and into the bloodstream. ▴ Fentanyl is more rapidly absorbed and bioavailability is higher from FBT than from the oral transmucosal fentanyl citrate formulation. ▴ In a well designed phase III trial in opioid-tolerant patients with cancer, a single dose of FBT 100–800μg provided clinically significant improvements in pain intensity from 15 to 60 minutes after the dose. ▴ Single FBT doses of 100–800μg were generally well tolerated; the majority of adverse events were mild to moderate in nature and typical of those associated with opioids.Keywords
This publication has 18 references indexed in Scilit:
- A Randomized, Placebo-controlled Study of Fentanyl Buccal Tablet for Breakthrough Pain in Opioid-treated Patients With CancerThe Clinical Journal of Pain, 2006
- Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1080 pg versus Oral transmucosal fentanyl citrate 1600 pg and dose proportionality of FEBT 270 to 1300 μg: A single-dose, randomized, open-label, three-period study in healthy adult volunteersClinical Therapeutics, 2006
- Pharmacokinetic properties of fentanyl effervescent buccal tablets: A phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 μg in healthy adult volunteersClinical Therapeutics, 2006
- Comparison of Equivalent Doses of Fentanyl Buccal Tablets and Arteriovenous Differences in Fentanyl PharmacokineticsClinical Pharmacokinetics, 2006
- Pharmacokinetics and Dose Proportionality of Fentanyl Effervescent Buccal Tablets in Healthy VolunteersClinical Pharmacokinetics, 2005
- Transdermal FentanylDrugs, 2001
- Breakthrough Cancer PainCNS Drugs, 2000
- An isobolographic analysis of the hypnotic effects of combinations of dexmedetomidine with fentanyl or diazepam in ratsLife Sciences, 1992
- Mechanism of Vasodilator Actions of Cromakalim in the Pulmonary Vascular System of the Cat.Anesthesia & Analgesia, 1990
- Interaction of Fentanyl and Pentobarbital on Peripheral and Cerebral Hemodynamics in Newborn LambsAnesthesiology, 1989